SLC44A1 and papillary glioneuronal tumor: Histologically and immunohistochemically, PGNT is not readily differentiated from other glioneuronal tumours; however, SLC44A1::PRKCA fusion appears to be unique to PGNT and is now regarded as its defining molecular feature [8, 9].